Skip to Content

25/250 SP 343 (Parcopa 25 mg / 250 mg)

Generic Name: carbidopa/levodopa

Pill with imprint 25/250 SP 343 is Blue, Round and has been identified as Parcopa 25 mg / 250 mg. It is supplied by Schwarz Pharma.

Parcopa is used in the treatment of parkinson's disease; neuroleptic malignant syndrome; gtp-ch deficiency and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Parcopa 25 mg / 250 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 25/250 SP 343

Parcopa 25 mg / 250 mg 25/250 SP 343

Parcopa

Generic Name
carbidopa/levodopa
Imprint
25/250 SP 343
Strength
25 mg / 250 mg
Color
Blue
Size
14.00 mm
Shape
Round
Availability
Prescription only
Drug Class
Dopaminergic antiparkinsonism agents
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Schwarz Pharma
National Drug Code (NDC)
00091-3343

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.